Banu Öztürk

2.5k total citations
118 papers, 1.2k citations indexed

About

Banu Öztürk is a scholar working on Oncology, Ophthalmology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Banu Öztürk has authored 118 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Oncology, 32 papers in Ophthalmology and 28 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Banu Öztürk's work include Glaucoma and retinal disorders (14 papers), Retinal Diseases and Treatments (12 papers) and Retinal Imaging and Analysis (11 papers). Banu Öztürk is often cited by papers focused on Glaucoma and retinal disorders (14 papers), Retinal Diseases and Treatments (12 papers) and Retinal Imaging and Analysis (11 papers). Banu Öztürk collaborates with scholars based in Türkiye, United Kingdom and United States. Banu Öztürk's co-authors include Banu Bozkurt, Hürkan Kerimoğlu, Uğur Çoşkun, Mustafa Beneklı, Emel Yaman, Süleyman Buyukberber, Kemal Gündüz, Süleyman Okudan, Ramazan Yıldız and Ali Kaya and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Banu Öztürk

110 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Banu Öztürk Türkiye 19 482 295 244 226 223 118 1.2k
Anna Balcerska Poland 18 104 0.2× 86 0.3× 271 1.1× 330 1.5× 171 0.8× 137 1.5k
Claudia Mendoza‐Pinto Mexico 25 177 0.4× 117 0.4× 115 0.5× 188 0.8× 116 0.5× 100 1.6k
François Chasset France 25 152 0.3× 289 1.0× 188 0.8× 160 0.7× 168 0.8× 108 1.9k
Daniel Goldman United States 25 122 0.3× 210 0.7× 190 0.8× 453 2.0× 96 0.4× 64 2.1k
Yeong Wook Song South Korea 19 84 0.2× 94 0.3× 87 0.4× 201 0.9× 87 0.4× 44 921
Elena Tagliabue Italy 19 57 0.1× 112 0.4× 113 0.5× 174 0.8× 180 0.8× 48 866
Alfred J. Fish United States 26 106 0.2× 380 1.3× 72 0.3× 403 1.8× 264 1.2× 47 2.2k
Dustan Kangave Saudi Arabia 31 1.7k 3.5× 571 1.9× 56 0.2× 262 1.2× 82 0.4× 49 2.1k
Ying Tan China 22 83 0.2× 298 1.0× 64 0.3× 249 1.1× 202 0.9× 88 1.7k
Esra Erden Türkiye 20 113 0.2× 68 0.2× 125 0.5× 129 0.6× 91 0.4× 90 1.3k

Countries citing papers authored by Banu Öztürk

Since Specialization
Citations

This map shows the geographic impact of Banu Öztürk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Banu Öztürk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Banu Öztürk more than expected).

Fields of papers citing papers by Banu Öztürk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Banu Öztürk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Banu Öztürk. The network helps show where Banu Öztürk may publish in the future.

Co-authorship network of co-authors of Banu Öztürk

This figure shows the co-authorship network connecting the top 25 collaborators of Banu Öztürk. A scholar is included among the top collaborators of Banu Öztürk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Banu Öztürk. Banu Öztürk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Kok, A., et al.. (2025). Deciphering the role of tRNA-derived fragments in neurological and psychiatric disease pathogenesis. Frontiers in Cellular Neuroscience. 19. 1663788–1663788.
4.
Öztürk, Banu, et al.. (2021). P-291 The prognostic and predictive factors for patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy. Annals of Oncology. 32. S196–S196. 1 indexed citations
5.
Öztürk, Banu, et al.. (2021). Short-Term Clinical Results of Preferred Retinal Locus Training. Turkish Journal of Ophthalmology. 52(1). 14–22. 4 indexed citations
6.
Erdem, Gökmen Umut, Mutlu Doğan, Abdullah Sakin, et al.. (2018). Non-Urothelial Bladder Cancer: Comparison of Clinicopathological and Prognostic Characteristics in Pure Adenocarcinoma and Non-Bilharzial Squamous Cell Carcinoma of the Bladder. Oncology Research and Treatment. 41(4). 220–225. 2 indexed citations
7.
Çakır, Mehtap, et al.. (2015). The Effect of Hypothyroidism on Color Contrast Sensitivity: A Prospective Study. European Thyroid Journal. 4(1). 43–47. 14 indexed citations
8.
Bakbak, Berker, et al.. (2013). Comparison of the Effect of Unilateral Intravitreal Bevacizumab and Ranibizumab Injection on Diabetic Macular Edema of the Fellow Eye. Journal of Ocular Pharmacology and Therapeutics. 29(8). 728–732. 36 indexed citations
9.
Kutlutürk, Faruk, Türker Taşlıyurt, Şafak Şahin, et al.. (2012). A Rare Complication of Antibiotic (Piperacillin/Tazobactam) Therapy: Resistant Hypokalemia. Journal of Medical Cases. 3(6). 355–357. 6 indexed citations
10.
Öztürk, Banu, Hürkan Kerimoğlu, Banu Bozkurt, & Süleyman Okudan. (2011). Comparison of Intravitreal Bevacizumab and Ranibizumab Treatment for Diabetic Macular Edema. Journal of Ocular Pharmacology and Therapeutics. 27(4). 373–377. 28 indexed citations
11.
Koç, Osman, et al.. (2011). Dural carotico-cavernous fistula: pre and postembolization appearances of bone-subtracted CT angiography. Turkish Neurosurgery. 23(2). 249–51. 1 indexed citations
12.
Demırcı, Umut, Uğur Çoşkun, Burcu Saka, et al.. (2010). Four different malignancies in one patient: a case report. Cases Journal. 3(1). 53–53. 5 indexed citations
13.
Kaya, Ali, Süleyman Buyukberber, Faysal Dane, et al.. (2010). Cisplatin plus docetaxel combination in the first-line treatment of metastatic non-small cell lung cancer.. PubMed. 96(3). 400–4. 2 indexed citations
14.
Öztürk, Banu, et al.. (2010). Ocular Changes Associated with Topiramate. Current Eye Research. 36(1). 47–52. 10 indexed citations
15.
Yaman, Emel, Banu Öztürk, Uğur Çoşkun, et al.. (2010). Synchronous Bilateral Breast Cancer in an Aged Male Patient. Onkologie. 33(5). 255–258. 6 indexed citations
16.
Kaya, Ali, et al.. (2009). Uterine Leiomyosarcoma Presenting with Neurological Symptoms: Differential Diagnosis. Turkiye Klinikleri Tip Bilimleri Dergisi. 29(1). 281–284.
17.
Şahi̇n, İdris, Beytullah Yıldırım, İlhan Çetin, et al.. (2009). Prevalence of Chronic Kidney Disease in the Black Sea Region, Turkey, and Investigation of the Related Factors with Chronic Kidney Disease. Renal Failure. 31(10). 920–927. 7 indexed citations
18.
Demırcı, Umut, Süleyman Buyukberber, Güldal Yılmaz, et al.. (2009). Coexistence Hodgkin’s lymphoma and colonic adenocarcinoma: a case report. Medical Oncology. 27(1). 62–64. 3 indexed citations
19.
Yıldırım, Beytullah, Banu Öztürk, Fikret Özuğurlu, et al.. (2008). Tokat ili erişkinleri'nde kolelitiazis sıklığı ve olası risk faktörleri*. 7(2). 83–86. 3 indexed citations
20.
Ceyhan, Ceyhun, et al.. (2004). Acute Transient Diastolic Dysfunction Induced by 5-Fluorouracil Treatment: A Case Report. Archives of the Turkish Society of Cardiology. 32(4). 262–265. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026